Get started

Moderna

Potential Double Bottom On Moderna (NASDAQ: $MRNA) 🧬Moderna, Inc., a biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases. As of March 9, 2021, the company had 13 programs in clinical trials and a total of 24 development programs in six modalities comprising prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted and cell surface therapeutics, and systemic intracellular therapeutics. The company has strategic alliances with AstraZeneca PLC, Merck & Co., Inc., Vertex Pharmaceuticals Incorporated, Vertex Pharmaceuticals (Europe) Limited, the Biomedical Advanced Research and Development Authority, the Defense Advanced Research Projects Agency, the National Institute of Allergy and Infectious Diseases, the National Institutes of Health, the Coalition for Epidemic Preparedness Innovations, Metagenomi, Inc., and Bill & Melinda Gates Foundation. Moderna, Inc. also has collaborations with Lonza Ltd.; Catalent Inc., Laboratorios Farmacéuticos Rovi, S.A., Recipharm, and Lonza Group; Aldevron, LLC; Institute for Life Changing Medicines; and AbCellera Biologics Inc. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
NASDAQ:MRNALong
by RedHotStocks
Keep Watching Moderrna Closely..!I monitored the Options data of Moderna in the next 8 weeks, and it seems there could be another bullish run..! But first, it must get out of the current downward orbit..! Education: In mathematics, specifically in the study of dynamical systems, an orbit is a collection of points related by the evolution function of the dynamical system. ... Understanding the properties of orbits by using topological methods is one of the objectives of the modern theory of dynamical systems. Some more professional materials:(research gate) "Do you really believe that markets can be stochastic and chaotic (deterministic) at the same time?" no, I never meant that's possible. these events are periodic and time-dependent. so neither is it possible to have two behaviors at the same time, which would mean a reversal of temporal events inexactitude, which would violate the Second law of thermodynamics. Financial markets exhibit stochastic behavior(Engle 1992), and recent studies so indicate that they also exhibit deterministic chaos(See Martin Casdagli), or chaos behavior. this may overlap in a discrete-time sense, since, by time-series analysis, we can determine many hidden properties in stock markets, not just patterns of chaos. something like chaotic patterns, or patterned chaos. You should classify between high-dimensional and low dimensional dynamics, the high-dimensional for stochastic and the low for chaos. Statistical forecasting techniques are useful to determine such temporal indeterminacy or chaos, and further, refining such models may bring down disorders in the time series analysis, but can never be zero. However, entropy in real can not decrease whereby if it does so only at the expense of increasing the entropy of some other systems, similar in financial markets where entropy is continuously transferred from one contemporaneity to another. "Can something be beautiful and ugly at the same time?" Paul, It much depends on the eyes of the beholders. So yes, it can be to some extent, but there is a generality of existential states. Mathematics does define properties of dynamical systems but one has to get the idea of what is the characteristic of such a dynamical system-how much dynamism is there, and how much is related to time? Here in stock markets, we say that the market is calm-but there is still some dynamism, or say very low dynamism, (which may be deterministic chaos) or fractals in essence due to extremely low trading activities. What triggers dynamic behavior in markets is different from weather dynamics, tidal waves, and other systems. It is what triggered human intentions(risk aversion, risk-taking, profit booking, more investment, or holding the portfolio) which trigger dynamic activities in the markets-and they balance well, if not, many things happen. (Sidharta Chatterjee) You can see the most important support(green line) and resistance (red line) levels. Best, Moshkelgosha DISCLAIMER I’m not a certified financial planner/advisor, a certified financial analyst, an economist, a CPA, an accountant, or a lawyer. I’m not a finance professional through formal education. The contents on this site are for informational purposes only and do not constitute financial, accounting, or legal advice. I can’t promise that the information shared on my posts is appropriate for you or anyone else. By using this site, you agree to hold me harmless from any ramifications, financial or otherwise, that occur to you as a result of acting on information found on this site. *You can see the most important support (green lines) and resistance (red lines) to watch in the coming days in these charts!(Based on Option wall data) **Yellow line Shows Maximum Pain level. ***You can see more details and educational materials by reviewing the previous posts!
NASDAQ:MRNALong
by Moshkelgosha
7
Covid strike back AGAINThe new covid strain "Omicorn" is spreading quickly all over the world. The obvious play for covid is investing in vaccines. PFE all time high is $61, currently its at $58. Where MRNA all time high is $500, currently its $248. Thats 50% discount from ATH. Technical: There is a clear strong support trend line that we're bouncing off. BlueWave is setting up to give a green dot buy signal (bottom wave green dot is the strongest of signals on bigger time frames)
NASDAQ:MRNALong
by MoonBets
6
Moderna Analysis 11.12.2021Hello Traders, welcome to this free and educational analysis. I am going to explain where I think this asset is going to go over the next few days and weeks and where I would look for trading opportunities. If you have any questions or suggestions which asset I should analyse tomorrow, please leave a comment below. If you enjoyed this analysis, I would definitely appreciate it, if you smash that like button and maybe consider following my channel. Thank you for watching and I will see you tomorrow!
NASDAQ:MRNA
by basictradingtv
100
Big Pharma Holds the LineLast week ended with sell-offs amid fears about the new extremely contagious COVID 19 Omicron variant. Crude and stock markets suffered. But during this brief rally some shares continued to gain, and it is no wonder that these are the stocks of vaccine producers. Pfizer stocks posted a new all-time high on Friday rising by 6.11% to $54.94. Stocks were additionally supported when the company promised to develop a tailor-made vaccine in 100 days if the Omicron variant cannot be tamed by the current vaccine. The shares also reacted to the news that the European Medicines Agency approved the BioNTech-Pfizer vaccine for children aged 5-11. That is good news for the world’s top-selling medicine of the year. In order for the shares to continue on this upside climb, the price of Pfizer stocks need to remain above $50.49, which is the shares’ peak which was reached in August, and also keep with its upward trend that started on November 4 and has a support level at $51.50-51.80. BioNTech stocks also performed well, adding some 14.19% on Friday. The technical picture suggests stocks may rise further as they managed to break through the downward channel they have been on since August 10. Besides, we may see a reverse pattern “double dip” with a neck level crossing $304.35. The implementation of this pattern may boost stock prices to $378.67-401.19. Stock prices are close to the 61.8% Fibonacci correction level of the lows of August-November at $365.13. In case this landmark is passed, investors will have more reasons to push the stock to this year’s highs. Moderna stocks also enjoyed the sunny side of the COVID-19 panic as they soared by 20.57% to $329.63 on Friday, breaking from their downward channel which began on September 23. The next price target is at the $387-395 area, where the 61.8% Fibonacci level from the downside correction of August-November, and the resistance line of the downward trend from August 10 are located. I have already said that all Big Pharma stocks should be included in portfolios as they may all rally. Nevertheless, at the beginning of the new week fears around the South African Omicron variant have faded as the virologist Barry Schoub, who advises the South African government, said he did not believe the variant will lead to a major new wave of serious illness and the vaccine will still protect most people from severe cases of COVID-19. But the overall picture now that there is a new variant in circulation is unclear, and the market may become agitated. In this case the best option is to have downside-resistant stocks in your portfolio. Some people may find profit anywhere!
NASDAQ:MRNALong
by scavoanastasiia
Moderna about to reclaim bullish Channel. Short-Term-BULLISH! Not financial advice! With the new corona variant spreading fear all over the world, PFE and MRNA are running. I think it's possible for MRNA to reclaim the bullish channel, aka the Bull-Trap that broke down, when PFE announced the Paxlovid-med. I got in MRNA way to late, now taking a risky trade, since MRNA gaps like crazy, and there's always the chance that it'll brake down to be traded at skipped price-levels. I think one should watch out for PFE announcing Paxlovid being effective against the omicron variant, which could lead a lot of investors to switch to PFE. Today I want to see MRNA reclaiming the bullish channel at $377,xx and hold within this channel. From there on, it's more than a 30% ride to the top of the channel. But this stock has done crazy things like this in the past. Depending on how fast MRNA manages to reclaim the top, the price correlates with the last ATH at $494,xx. I think, if it manages to get back at the center of the channel, it will be rejected at the old resistance at $463,xx first, settle a bit and then trying to break the $500. My plan is to sell at $463 and then watch how things develop. But remember if, you're not in it by now, it maybe is bad timing to get in at this pricelevel. Risk is way to high, because of the gaps. That is why I marked this trading strategy as Neutral. Good luck in the markets! Again, this is not financial advice!
NASDAQ:MRNA
by robvanhoven
Are Pfizer, Merck and Moderna Still Worthy to Be in Portfolio?Pfizer is now outperforming Merck and Moderna stocks after announcing its anti-COVID pill despite its shares not being the best option for investments in the first half of this year. Pfizer stocks gained only 35% since the beginning of this year until mid-August. Moderna stocks were skyrocketed by 375% for the same period. So, undoubtedly Moderna was the favourite. However, when Merck announced the production of its COVID pills, the shares of vaccine producers spiraled into correction. But Merck was not the one to get its COVID pills into the market. Its shares peaked up to $91.40 and plunged with a gap after Pfizer announced its even more promising COVID treatment pills. The company said clinical trials showed that hospitalisation and deaths were reduced by 89% when the pill is taken within three days of the onset of symptoms.  So, this news from Pfizer came on November 5 and since then the technical picture for the above-mentioned three Big Pharma stocks changed dramatically. Pfizer shares are taking the lead while waving away all their August corrections and now they are close to the all-time highs at $51.86. If they are successful at breaking through this level, technical price acceleration may bring its stocks to $56.03 and $58.60 may be the next target. These levels could be a correction impulse to the decline from $51.86 to $40.94 per share. The nearest support level is at $47.70-48.80. As for Moderna stocks, the last quarter financial report hit them badly. Nevertheless, impulsive selloffs are now over as shares dipped to the important support level established in November 2020. So, now it is worth consider buying these shares. Corrections went into an ABC zigzag and shares are likely to return on the upside track. Initially, A and B waves were suggested to be equal, but now we see that the C wave is 161.8% of the A wave that gave us a decline to $225.85 per share. In my opinion Moderna shares have accomplished their correction and are close to the trend line of the last 12 month, and for that reason are an interesting investment. So, Moderna stocks may even be catching up to Pfizer. The nearest targets for Moderna stocks are within the area of $283-291 where EMA 21 moving average is located at the daily timeframe chart together with the resistance level formed by dips of July and October 2021. Moreover, at the $298 landmark, the resistance line of the downward trend that started on September 23 is located. If this zone would be broken the perspectives for Moderna stocks should be extended.Despite all these different technical pictures for these stocks, I would recommend holding all three stocks in your investment portfolio. Pfizer and Merck continue to compete in the COVID pills market while Moderna has a forward P/E ratio at 9, which highlights that the company is the cheapest among the Big Pharma biotech companies if compared with its peers sector performance.
NASDAQ:MRNALong
by scavoanastasiia
Moderna (MRNA) Swing Trade IdeaModerna broke trend to the downside, so long term view is more likely a short rather than long. As illustrated in the chart, I wouldn't short at current prices, but around the red level I have drawn. The trade is invalidated if it closes above the red zone with high volume. If it closes above it but on low volume, it could be a fake out with the following candles closing below it once again. The red zone at the very top is the next resistance zone if it does get through the first resistance zone. Please disregard the overall timeframe estimate, it can take longer or shorter for this trade to play out, but the move is the general idea.
NASDAQ:MRNAShort
by wallstreetnomad
3
Moderna sliding back to Earth. MRNAPivot on a huge impulse fractal confirmed. We are drawing more and more zigzags from now on. Our goals are shown. We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels that the market will go to. Having said that, the market will always do what it wants and always has a mind of its own. Therefore, none of this is financial advice, so do your own research and rely only on your own analysis. Trading is a true one man sport. Good luck out there and stay safe!
NASDAQ:MRNAShort
by Rykin_Capital